Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2003 Feb;12(1):3–8. doi: 10.1080/0962935031000096917

Human intestinal epithelial and smooth muscle cells are potent producers of IL-6.

Edmond K Ng 1, Ninder Panesar 1, Walter E Longo 1, Marc J Shapiro 1, Donald L Kaminski 1, Kym C Tolman 1, John E Mazuski 1
PMCID: PMC1781593  PMID: 12745542

Abstract

BACKGROUND: Interleukin-6 (IL-6), a pluripotent cytokine, has traditionally been considered the product of proinflammatory cells. However, many other cell types have been shown to produce IL-6. Since intestinal inflammation is commonly associated with a vigorous systemic inflammatory response, we hypothesized that intestinal epithelial and smooth muscle cells might contribute to that response by producing IL-6. We therefore studied the capacity of differentiated human intestinal epithelial and smooth muscle cell lines to produce IL-6 in response to various proinflammatory stimuli. MATERIALS AND METHODS: CCL-241, a human intestinal epithelial cell line, and HISM, a human intestinal muscle cell line, were grown to confluency and then treated for 24 h with various concentrations of lipopolysaccharide, Clostridium difficile culture extract containing both toxin A and toxin B, recombinant human tumor necrosis factor-alpha (TNF-alpha), or recombinant human interleukin-1 beta (IL-1beta). Supernatants were then collected for IL-6 determination using an enzyme-linked immunosorbent assay. Cell numbers were determined using a Coulter counter. For comparison, parallel studies were performed using phorbol ester-primed U-937 and THP-1 human macrophage cell lines. RESULTS: Both human intestinal epithelial and smooth muscle cells produced IL-6 under basal conditions. In HISM cells, but not in CCL-241 cells, IL-6 release was increased slightly by treatment with C. difficile culture extract containing both toxin A and toxin B and with lipopolysaccharide. In both cell lines, IL-6 production was profoundly stimulated by treatment with IL-1beta and less so with TNF-alpha. Combinations of high-dose TNF-alpha and IL-1beta may have a slightly additive, but not synergistic, effect on IL-6 release. The amount of IL-6 produced by IL-1-stimulated intestinal cell lines was 70-fold higher than that produced by stimulated macrophage cell lines. CONCLUSIONS; Both intestinal epithelial and smooth muscle cells demonstrate the ability to release significant amounts of IL-6. The profound response to IL-1beta and TNF-alpha stimulation by both cell lines suggests that human intestinal parenchymal cells, influenced by paracrine mediators liberated from proinflammatory cells, might significantly contribute to the overall systemic inflammatory response by producing IL-6.

Full Text

The Full Text of this article is available as a PDF (104.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. C., Lust J. A. Role of cytokines in multiple myeloma. Semin Hematol. 1999 Jan;36(1 Suppl 3):14–20. [PubMed] [Google Scholar]
  2. Arai F., Takahashi T., Furukawa K., Matsushima K., Asakura H. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease. Dig Dis Sci. 1998 Sep;43(9):2071–2079. doi: 10.1023/a:1018815432504. [DOI] [PubMed] [Google Scholar]
  3. Barkhudaryan N., Dunn A. J. Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis. Neurochem Res. 1999 Sep;24(9):1169–1180. doi: 10.1023/a:1020720722209. [DOI] [PubMed] [Google Scholar]
  4. Beschorner W. E., Civin C. I., Strauss L. C. Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. Am J Pathol. 1985 Apr;119(1):1–4. [PMC free article] [PubMed] [Google Scholar]
  5. Callery M. P., Kamei T., Flye M. W. Endotoxin stimulates interleukin-6 production by human Kupffer cells. Circ Shock. 1992 Jul;37(3):185–188. [PubMed] [Google Scholar]
  6. Carroll G., Bell M., Wang H., Chapman H., Mills J. Antagonism of the IL-6 cytokine subfamily--a potential strategy for more effective therapy in rheumatoid arthritis. Inflamm Res. 1998 Jan;47(1):1–7. doi: 10.1007/s000110050235. [DOI] [PubMed] [Google Scholar]
  7. Fayyazi A., Sandau R., Duong L. Q., Götze O., Radzun H. J., Schweyer S., Soruri A., Zwirner J. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells. Am J Pathol. 1999 Feb;154(2):495–501. doi: 10.1016/S0002-9440(10)65295-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fey G. H., Gauldie J. The acute phase response of the liver in inflammation. Prog Liver Dis. 1990;9:89–116. [PubMed] [Google Scholar]
  9. Fried S. K., Bunkin D. A., Greenberg A. S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998 Mar;83(3):847–850. doi: 10.1210/jcem.83.3.4660. [DOI] [PubMed] [Google Scholar]
  10. Fukushima K., Sasaki I., Takahashi K., Naito H., Matsuno S. Lipopolysaccharide- and proinflammatory cytokine-induced energy production in intestinal and colonic epithelial cell lines. Scand J Gastroenterol. 1999 Mar;34(3):291–296. doi: 10.1080/00365529950173717. [DOI] [PubMed] [Google Scholar]
  11. Goodrich M. E., McGee D. W. Effect of intestinal epithelial cell cytokines on mucosal B-cell IgA secretion: enhancing effect of epithelial-derived IL-6 but not TGF-beta on IgA+ B cells. Immunol Lett. 1999 Mar 15;67(1):11–14. doi: 10.1016/s0165-2478(98)00112-6. [DOI] [PubMed] [Google Scholar]
  12. Gotteland M., Lopez M., Muñoz C., Saez R., Altshiller H., Llorens P., Brunser O. Local and systemic liberation of proinflammatory cytokines in ulcerative colitis. Dig Dis Sci. 1999 Apr;44(4):830–835. doi: 10.1023/a:1026690631693. [DOI] [PubMed] [Google Scholar]
  13. Grottrup-Wolfers E., Moeller J., Karbach U., Muller-Lissner S., Endres S. Elevated cell-associated levels of interleukin 1beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease. Eur J Clin Invest. 1996 Feb;26(2):115–122. doi: 10.1046/j.1365-2362.1996.123262.x. [DOI] [PubMed] [Google Scholar]
  14. Hayashi M., Martinez O. M., Krams S. M., Burns W., Esquivel C. O. Characterization of allograft rejection in an experimental model of small intestinal transplantation. J Gastrointest Surg. 1998 Jul-Aug;2(4):325–332. doi: 10.1016/s1091-255x(98)80071-1. [DOI] [PubMed] [Google Scholar]
  15. Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990 Feb 1;265(3):621–636. doi: 10.1042/bj2650621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Helfgott D. C., May L. T., Sthoeger Z., Tamm I., Sehgal P. B. Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts. J Exp Med. 1987 Nov 1;166(5):1300–1309. doi: 10.1084/jem.166.5.1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hierholzer C., Kalff J. C., Audolfsson G., Billiar T. R., Tweardy D. J., Bauer A. J. Molecular and functional contractile sequelae of rat intestinal ischemia/reperfusion injury. Transplantation. 1999 Nov 15;68(9):1244–1254. doi: 10.1097/00007890-199911150-00006. [DOI] [PubMed] [Google Scholar]
  18. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today. 1990 Dec;11(12):443–449. doi: 10.1016/0167-5699(90)90173-7. [DOI] [PubMed] [Google Scholar]
  19. Holtkamp W., Stollberg T., Reis H. E. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol. 1995 Mar;20(2):123–126. doi: 10.1097/00004836-199503000-00010. [DOI] [PubMed] [Google Scholar]
  20. Holub M. C., Makó E., Dévay T., Dank M., Szalai C., Fenyvesi A., Falus A. Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease. Scand J Gastroenterol Suppl. 1998;228:47–50. [PubMed] [Google Scholar]
  21. Hosokawa T., Kusugami K., Ina K., Ando T., Shinoda M., Imada A., Ohsuga M., Sakai T., Matsuura T., Ito K. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease. J Gastroenterol Hepatol. 1999 Oct;14(10):987–996. doi: 10.1046/j.1440-1746.1999.01989.x. [DOI] [PubMed] [Google Scholar]
  22. Ishiguro Y. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol. 1999 Feb;34(1):66–74. doi: 10.1007/s005350050218. [DOI] [PubMed] [Google Scholar]
  23. Jirik F. R., Podor T. J., Hirano T., Kishimoto T., Loskutoff D. J., Carson D. A., Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 1989 Jan 1;142(1):144–147. [PubMed] [Google Scholar]
  24. Jones S. C., Crabtree J. E., Rembacken B. J., Dixon M. F., Trejdosiewicz L. K., Whicher J. T., Axon A. T. Mucosal interleukin-6 secretion in ulcerative colitis. Effects of anti-inflammatory drugs and T-cell stimulation. Scand J Gastroenterol. 1994 Aug;29(8):722–728. doi: 10.3109/00365529409092500. [DOI] [PubMed] [Google Scholar]
  25. Jones S. C., Trejdosiewicz L. K., Banks R. E., Howdle P. D., Axon A. T., Dixon M. F., Whicher J. T. Expression of interleukin-6 by intestinal enterocytes. J Clin Pathol. 1993 Dec;46(12):1097–1100. doi: 10.1136/jcp.46.12.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kapadia S., Dibbs Z., Kurrelmeyer K., Kalra D., Seta Y., Wang F., Bozkurt B., Oral H., Sivasubramanian N., Mann D. L. The role of cytokines in the failing human heart. Cardiol Clin. 1998 Nov;16(4):645-56, viii. doi: 10.1016/s0733-8651(05)70041-2. [DOI] [PubMed] [Google Scholar]
  27. Khan I., Blennerhassett M. G., Kataeva G. V., Collins S. M. Interleukin 1 beta induces the expression of interleukin 6 in rat intestinal smooth muscle cells. Gastroenterology. 1995 Jun;108(6):1720–1728. doi: 10.1016/0016-5085(95)90133-7. [DOI] [PubMed] [Google Scholar]
  28. Kirnbauer R., Köck A., Schwarz T., Urbanski A., Krutmann J., Borth W., Damm D., Shipley G., Ansel J. C., Luger T. A. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol. 1989 Mar 15;142(6):1922–1928. [PubMed] [Google Scholar]
  29. Kusugami K., Fukatsu A., Tanimoto M., Shinoda M., Haruta J., Kuroiwa A., Ina K., Kanayama K., Ando T., Matsuura T. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Dig Dis Sci. 1995 May;40(5):949–959. doi: 10.1007/BF02064182. [DOI] [PubMed] [Google Scholar]
  30. LeMay L. G., Vander A. J., Kluger M. J. Role of interleukin 6 in fever in rats. Am J Physiol. 1990 Mar;258(3 Pt 2):R798–R803. doi: 10.1152/ajpregu.1990.258.3.R798. [DOI] [PubMed] [Google Scholar]
  31. Manolagas S. C. The role of IL-6 type cytokines and their receptors in bone. Ann N Y Acad Sci. 1998 May 1;840:194–204. doi: 10.1111/j.1749-6632.1998.tb09563.x. [DOI] [PubMed] [Google Scholar]
  32. Mazuski J. E., Tolman K., Shapiro M. J. Effects of cytokine antagonists on the hepatic acute-phase response. J Surg Res. 1997 Mar;68(2):161–169. doi: 10.1006/jsre.1997.4999. [DOI] [PubMed] [Google Scholar]
  33. McAlindon M. E., Mahida Y. R. Pro-inflammatory cytokines in inflammatory bowel disease. Aliment Pharmacol Ther. 1996;10 (Suppl 2):72–74. doi: 10.1046/j.1365-2036.1996.22164023.x. [DOI] [PubMed] [Google Scholar]
  34. Mitsuyama K., Sasaki E., Toyonaga A., Ikeda H., Tsuruta O., Irie A., Arima N., Oriishi T., Harada K., Fujisaki K. Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion. 1991;50(2):104–111. doi: 10.1159/000200747. [DOI] [PubMed] [Google Scholar]
  35. Navarro S., Debili N., Bernaudin J. F., Vainchenker W., Doly J. Regulation of the expression of IL-6 in human monocytes. J Immunol. 1989 Jun 15;142(12):4339–4345. [PubMed] [Google Scholar]
  36. Neipel F., Albrecht J. C., Fleckenstein B. Human herpesvirus 8--the first human Rhadinovirus. J Natl Cancer Inst Monogr. 1998;(23):73–77. doi: 10.1093/oxfordjournals.jncimonographs.a024178. [DOI] [PubMed] [Google Scholar]
  37. Panesar N., Tolman K., Mazuski J. E. Endotoxin stimulates hepatocyte interleukin-6 production. J Surg Res. 1999 Aug;85(2):251–258. doi: 10.1006/jsre.1999.5648. [DOI] [PubMed] [Google Scholar]
  38. Papanicolaou D. A., Wilder R. L., Manolagas S. C., Chrousos G. P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998 Jan 15;128(2):127–137. doi: 10.7326/0003-4819-128-2-199801150-00009. [DOI] [PubMed] [Google Scholar]
  39. Reimund J. M., Wittersheim C., Dumont S., Muller C. D., Kenney J. S., Baumann R., Poindron P., Duclos B. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut. 1996 Nov;39(5):684–689. doi: 10.1136/gut.39.5.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Reinecker H. C., Steffen M., Witthoeft T., Pflueger I., Schreiber S., MacDermott R. P., Raedler A. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1993 Oct;94(1):174–181. doi: 10.1111/j.1365-2249.1993.tb05997.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Reinisch W., Gasché C., Tillinger W., Wyatt J., Lichtenberger C., Willheim M., Dejaco C., Waldhör T., Bakos S., Vogelsang H. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol. 1999 Aug;94(8):2156–2164. doi: 10.1111/j.1572-0241.1999.01288.x. [DOI] [PubMed] [Google Scholar]
  42. Sher M. E., D'Angelo A. J., Stein T. A., Bailey B., Burns G., Wise L. Cytokines in Crohn's colitis. Am J Surg. 1995 Jan;169(1):133–136. doi: 10.1016/s0002-9610(99)80121-4. [DOI] [PubMed] [Google Scholar]
  43. Sironi M., Breviario F., Proserpio P., Biondi A., Vecchi A., Van Damme J., Dejana E., Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J Immunol. 1989 Jan 15;142(2):549–553. [PubMed] [Google Scholar]
  44. Strong S. A., Pizarro T. T., Klein J. S., Cominelli F., Fiocchi C. Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells. Gastroenterology. 1998 Jun;114(6):1244–1256. doi: 10.1016/s0016-5085(98)70431-7. [DOI] [PubMed] [Google Scholar]
  45. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T., Tada K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982 Apr;42(4):1530–1536. [PubMed] [Google Scholar]
  46. Van Assche G., Barbara G., Deng Y., Lovato P., Gauldie J., Collins S. M. Neurotransmitters modulate cytokine-stimulated interleukin 6 secretion in rat intestinal smooth muscle cells. Gastroenterology. 1999 Feb;116(2):346–353. doi: 10.1016/s0016-5085(99)70131-9. [DOI] [PubMed] [Google Scholar]
  47. Walgenbach K. J., Heeckt P. F., Kalff J. C., Stanson J., Whiteside T. L., Hirner A., Bauer A. J. Increase of interleukin-6 in the intestinal mucosa and muscularis following chronic rejection after small bowel transplantation. Transplant Proc. 1998 Sep;30(6):2600–2600. doi: 10.1016/s0041-1345(98)00745-3. [DOI] [PubMed] [Google Scholar]
  48. Woywodt A., Ludwig D., Neustock P., Kruse A., Schwarting K., Jantschek G., Kirchner H., Stange E. F. Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1999 Mar;11(3):267–276. doi: 10.1097/00042737-199903000-00010. [DOI] [PubMed] [Google Scholar]
  49. van Tol E. A., Holt L., Li F. L., Kong F. M., Rippe R., Yamauchi M., Pucilowska J., Lund P. K., Sartor R. B. Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. Am J Physiol. 1999 Jul;277(1 Pt 1):G245–G255. doi: 10.1152/ajpgi.1999.277.1.G245. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES